Champions Oncology, Inc. – NASDAQ:CSBR
Champions Oncology stock price today
$7.62
-0.72
-8.74%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 1 hour
Champions Oncology stock price monthly change
+65.02%
month
Champions Oncology stock price quarterly change
+65.02%
quarter
Champions Oncology stock price yearly change
+57.70%
year
Champions Oncology key metrics
Market Cap | 105.30M |
Enterprise value | 60.97M |
P/E | -19.59 |
EV/Sales | 1.13 |
EV/EBITDA | -72.50 |
Price/Sales | 1.18 |
Price/Book | 9.02 |
PEG ratio | -0.58 |
EPS | -0.58 |
Revenue | 50.74M |
EBITDA | -4.40M |
Income | -7.87M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -5.81% |
Oper. margin | -5.67% |
Gross margin | 47.06% |
EBIT margin | -5.67% |
EBITDA margin | -8.69% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChampions Oncology stock price history
Champions Oncology stock forecast
Champions Oncology financial statements
| Apr 2022 | 12.87M | -344K | -2.67% |
|---|---|---|---|
| Jan 2023 | 12.77M | -2.43M | -19.09% |
| Apr 2023 | 13.07M | -2.56M | -19.59% |
| Jan 2024 | 12.01M | -2.53M | -21.05% |
| 2026 | 59.31M | 677.07K | 1.14% |
|---|---|---|---|
| 2027 | 66.72M | 0 |
Analysts Price target
Financials & Ratios estimates
| 2024-07-18 | -0.16 | -0.01 |
|---|---|---|
| 2024-09-11 | 0.01941 | 0.11 |
| Oct 2022 | 36364000 | 27.19M | 74.78% |
|---|---|---|---|
| Jan 2023 | 36151000 | 29.08M | 80.46% |
| Apr 2023 | 34311000 | 29.67M | 86.49% |
| Jan 2024 | 26787000 | 28.84M | 107.68% |
| Apr 2022 | 796K | -506K | 16K |
|---|---|---|---|
| Jan 2023 | 1.57M | -754K | 0 |
| Apr 2023 | -709K | -760K | -75K |
| Jan 2024 | -919K | -126K | 0 |
Champions Oncology alternative data
| Aug 2023 | 230 |
|---|---|
| Sep 2023 | 230 |
| Oct 2023 | 230 |
| Nov 2023 | 230 |
| Dec 2023 | 230 |
| Jan 2024 | 230 |
| Feb 2024 | 230 |
| Mar 2024 | 230 |
| Apr 2024 | 230 |
| May 2024 | 230 |
| Jun 2024 | 230 |
| Jul 2024 | 230 |
Champions Oncology other data
10.08%
-34.30%
of CSBR is owned by hedge funds
17
-10
1.36M
-4.63M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2023 | 12382 | 0 |
| Sep 2023 | 22830 | 0 |
| Oct 2023 | 17130 | 0 |
| Dec 2023 | 9600 | 0 |
| Jan 2024 | 15444 | 0 |
| Quarter | Transcript |
|---|---|
| Q3 2024 12 Mar 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 12 Dec 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 15 Sep 2023 | Q1 2024 Earnings Call Transcript |
| Q4 2023 24 Jul 2023 | Q4 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Ronnie Morris M.D. (1966) Pres, Chief Executive Officer & Director | $775,000 |
Mr. David Barry Miller M.B.A. (1969) Chief Financial Officer | $285,000 |
-
What's the price of Champions Oncology stock today?
One share of Champions Oncology stock can currently be purchased for approximately $7.62.
-
When is Champions Oncology's next earnings date?
Unfortunately, Champions Oncology's (CSBR) next earnings date is currently unknown.
-
Does Champions Oncology pay dividends?
No, Champions Oncology does not pay dividends.
-
How much money does Champions Oncology make?
Champions Oncology has a market capitalization of 105.30M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6.9% to 50.16M US dollars. Champions Oncology made a loss 7.28M US dollars in net income (profit) last year or $0.11 on an earnings per share basis.
-
What is Champions Oncology's stock symbol?
Champions Oncology, Inc. is traded on the NASDAQ under the ticker symbol "CSBR".
-
What is Champions Oncology's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Champions Oncology?
Shares of Champions Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Champions Oncology's key executives?
Champions Oncology's management team includes the following people:
- Dr. Ronnie Morris M.D. Pres, Chief Executive Officer & Director(age: 59, pay: $775,000)
- Mr. David Barry Miller M.B.A. Chief Financial Officer(age: 56, pay: $285,000)
-
How many employees does Champions Oncology have?
As Jul 2024, Champions Oncology employs 230 workers.
-
When Champions Oncology went public?
Champions Oncology, Inc. is publicly traded company for more then 18 years since IPO on 2 Feb 2007.
-
What is Champions Oncology's official website?
The official website for Champions Oncology is championsoncology.com.
-
Where are Champions Oncology's headquarters?
Champions Oncology is headquartered at One University Plaza, Hackensack, NJ.
-
How can i contact Champions Oncology?
Champions Oncology's mailing address is One University Plaza, Hackensack, NJ and company can be reached via phone at +20 18088400.
Champions Oncology company profile:
Champions Oncology, Inc.
championsoncology.comExchange:
NASDAQ
Full time employees:
210
Industry:
Biotechnology
Sector:
Healthcare
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
One University Plaza
Hackensack, NJ 07601
Hackensack, NJ 07601
CIK: 0000771856
ISIN: US15870P3073
CUSIP: 15870P307
